Viewing StudyNCT02448420



Ignite Creation Date: 2024-05-06 @ 4:03 AM
Last Modification Date: 2024-10-26 @ 11:43 AM
Study NCT ID: NCT02448420
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2015-05-08

Brief Title: Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Sponsor: SOLTI Breast Cancer Research Group
Organization: SOLTI Breast Cancer Research Group

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords: